InMed Pharmaceuticals Inc. - 8-K Filing
Mentari Therapeutics completes merger with InMed Pharmaceuticals and secures $490 million in private financing (Items: 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)
Tickers: $INM
Read the full article at SEC EDGAR
Part of the story First Breach, Inc. - 8-K Filing (3 articles)